Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Acylation through Ketene Intermediates.

Shelkov R, Nahmany M, Melman A.

J Org Chem. 2002 Dec 13;67(25):8975-82.

PMID:
12467417
2.

Highly selective hydrolytic kinetic resolution of terminal epoxides catalyzed by chiral (salen)Co(III) complexes. Practical synthesis of enantioenriched terminal epoxides and 1,2-diols.

Schaus SE, Brandes BD, Larrow JF, Tokunaga M, Hansen KB, Gould AE, Furrow ME, Jacobsen EN.

J Am Chem Soc. 2002 Feb 20;124(7):1307-15.

PMID:
11841300
3.

Synthesis and diastereoselective reactions of n,n-dibenzylamino aldehydes and related compounds.

Reetz MT.

Chem Rev. 1999 May 12;99(5):1121-62. No abstract available.

PMID:
11749442
4.
5.

Synthesis of C-protected alpha-amino aldehydes of high enantiomeric excess from highly epimerizable N-protected alpha-amino aldehydes.

Myers AG, Zhong B, Kung DW, Movassaghi M, Lanman BA, Kwon S.

Org Lett. 2000 Oct 19;2(21):3337-40.

PMID:
11029204
6.

Cytochalasin E, an epoxide containing Aspergillus-derived fungal metabolite, inhibits angiogenesis and tumor growth.

Udagawa T, Yuan J, Panigrahy D, Chang YH, Shah J, D'Amato RJ.

J Pharmacol Exp Ther. 2000 Aug;294(2):421-7.

7.

Disruption of actin microfilaments by cytochalasin D leads to activation of p53.

Rubtsova SN, Kondratov RV, Kopnin PB, Chumakov PM, Kopnin BP, Vasiliev JM.

FEBS Lett. 1998 Jul 3;430(3):353-7.

8.

Structure of cytochalasins and cytochalasin B binding sites in human erythrocyte membranes.

Rampal AL, Pinkofsky HB, Jung CY.

Biochemistry. 1980 Feb 19;19(4):679-83.

PMID:
7356953
9.

Microfilaments in cellular and developmental processes.

Wessells NK, Spooner BS, Ash JF, Bradley MO, Luduena MA, Taylor EL, Wrenn JT, Yamada K.

Science. 1971 Jan 15;171(3967):135-43.

PMID:
5538822
11.

Effects of cytochalasin and phalloidin on actin.

Cooper JA.

J Cell Biol. 1987 Oct;105(4):1473-8. Review. No abstract available.

12.

L-696,474, a novel cytochalasin as an inhibitor of HIV-1 protease. III. Biological activity.

Lingham RB, Hsu A, Silverman KC, Bills GF, Dombrowski A, Goldman ME, Darke PL, Huang L, Koch G, Ondeyka JG, et al.

J Antibiot (Tokyo). 1992 May;45(5):686-91.

13.

L-696,474, a novel cytochalasin as an inhibitor of HIV-1 protease. II. Isolation and structure.

Ondeyka J, Hensens OD, Zink D, Ball R, Lingham RB, Bills G, Dombrowski A, Goetz M.

J Antibiot (Tokyo). 1992 May;45(5):679-85.

14.

L-696,474, a novel cytochalasin as an inhibitor of HIV-1 protease. I. The producing organism and its fermentation.

Dombrowski AW, Bills GF, Sabnis G, Koupal LR, Meyer R, Ondeyka JG, Giacobbe RA, Monaghan RL, Lingham RB.

J Antibiot (Tokyo). 1992 May;45(5):671-8.

15.

Letter: Synthesis of the isoindolone nucleus of the cytochalasins.

Auerbach J, Weinreb SM.

J Org Chem. 1975 Oct 31;40(22):3311-2. No abstract available.

PMID:
1185311

Supplemental Content

Support Center